# RALPPS Venus ALPPS for Hepatocellular Carcinoma

> **NCT02299843** · NA · UNKNOWN · sponsor: **Southwest Hospital, China** · enrollment: 32 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** RALPPS
- **PROCEDURE:** ALPPS

## Key facts

- **NCT ID:** NCT02299843
- **Lead sponsor:** Southwest Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02299843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02299843, "RALPPS Venus ALPPS for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02299843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*